Celon Pharma S.A. Logo

Celon Pharma S.A.

An integrated pharmaceutical company researching and manufacturing modern drugs.

CLN | WAR

Overview

Corporate Details

ISIN(s):
PLCLNPH00015 (+3 more)
LEI:
259400Q0ERJT0NC5DT24
Country:
Poland
Address:
KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY

Description

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-06-18 15:21
Rejestracja leku Salmex na rynku w Hondurasie - Content (PL)
Polish 941 bytes
2018-06-07 21:04
Żądanie umieszczenia spraw w porządku obrad ZWZ
Polish 1.5 MB
2018-06-07 21:04
Wniosek Akcjonariusza o rozszerzenie porządku obrad oraz zgłoszenie projektów u…
Polish 4.2 KB
2018-06-07 20:52
Zawiadomienie o zawarciu porozumienia
Polish 885.6 KB
2018-06-07 20:52
Zawiadomienie o zawarciu porozumienia akcjonariuszy. - Content (PL)
Polish 476 bytes
2018-06-01 18:11
Projekty uchwał na ZWZ GLG Pharma SA zwołane na dzień 29 czerwca 2018 r
Polish 264.6 KB
2018-06-01 18:11
Treść ogłoszenia o zwołaniu Zwyczajnego Walnego Zgromadzenia GLG Pharma SA na d…
Polish 462.8 KB
2018-06-01 18:11
Zwołanie Zwyczajnego Walnego Zgromadzenia GLG Pharma S.A. na dzień 29 czerwca 2…
Polish 665 bytes
2018-05-30 17:43
Ujawnienie opóźnionej informacji poufnej. - Content (PL)
Polish 3.3 KB
2018-05-24 15:30
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 860 bytes
2018-05-24 08:05
Zakończenie zdecentralizowanej procedury rejestracyjnej dla leku Salmex na rynk…
Polish 1.1 KB
2018-05-23 18:33
Uchwały podjęte przez ZWZ Celon Pharma 23052018
Polish 253.7 KB
2018-05-23 18:33
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie Celon Pharma S.A. w dniu 23 …
Polish 493 bytes
2018-05-23 15:31
Uchwała Zwyczajnego Walnego Zgromadzenia Spółki w sprawie wypłaty dywidendy - C…
Polish 880 bytes
2018-05-22 14:09
Zakończenie III części badania klinicznego I fazy nad lekiem opartym na Esketam…
Polish 1.1 KB

Automate Your Workflow. Get a real-time feed of all Celon Pharma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celon Pharma S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celon Pharma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.